Skip to main content
Primary Open Angle GlaucomaVision and hearingDeviceProcedure

What this study is

A prospective, multicenter, randomized, single-masked, post-market clinical trial comparing cataract surgery in conjunction with ab-interno canaloplasty utilizing the iTrack Advance canaloplasty device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 24 months.

What's being tested

  • Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device

    Intervention · DEVICE

    360 degree microcatheterization and viscodilation of Schlemm's canal

  • Cataract surgery

    Intervention · PROCEDURE

    Cataract surgery alone

Study details

Sponsor
Nova Eye, Inc.
Conditions
Primary Open Angle Glaucoma
Enrolling
78 people
Starts
2022-09-08
Est. completion
2027-07
Design
Single-blind, randomized, factorial
Record
View on ClinicalTrials.gov ↗